NCT07007156

Brief Summary

The aim of the present study is to evaluate the usefulness of the NECPAL scale in identifying Intensive Care Unit (ICU)-admitted patients at higher risk of dying within 90 days of ICU admission

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
199

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Jun 2025Jan 2027

First Submitted

Initial submission to the registry

May 28, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 5, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

June 12, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

December 5, 2025

Status Verified

December 1, 2025

Enrollment Period

1.6 years

First QC Date

May 28, 2025

Last Update Submit

December 1, 2025

Conditions

Acute Disease

Keywords

Acute DiseaseIntensive Care Unit

Outcome Measures

Primary Outcomes (1)

  • Mortality

    Patients who dye at 90-day from ICU admission

    From baseline to 90-day

Interventions

NECPAL positiveOTHER

This group has a positive result for NECPAL scale

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 75 years or older who are admitted to an ICU

You may qualify if:

  • Men and women aged 75 years or older.
  • Admission to the ICU of the study center.
  • Legal capacity to provide informed consent.

You may not qualify if:

  • Death within the first 24 hours of ICU admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CSAPG

Sant Pere de Ribes, Barcelona, 08800, Spain

RECRUITING

MeSH Terms

Conditions

Acute Disease

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Diana Gutiérrez, MD

    CSAPG

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Diana Gutiérrez, MD

CONTACT

+34938960025dpgutierrez@csapg.cat

Noemí Casaponsa

CONTACT

+34 938960025recerca@csapg.cat

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2025

First Posted

June 5, 2025

Study Start

June 12, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Last Updated

December 5, 2025

Record last verified: 2025-12

Locations

ES(1)